Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Human cytochrome P450 3A4 (CYP3A4) is a crucial enzyme in drug metabolism.
• Its large active site allows for promiscuous substrate binding and potential allosteric effects.
• Understanding how multiple substrates bind is vital due to difficulties in crystallizing CYP3A4-substrate complexes.

Purpose of the Study:

• To determine the structural basis of multiple substrate binding in CYP3A4.
• To elucidate the arrangement of caffeine molecules within the CYP3A4 active site and associated regions.
• To investigate the implications for enzyme activity and drug-drug interactions.

Main Methods:

• X-ray crystallography to obtain high-resolution structures of CYP3A4 with bound caffeine.
• Spectroscopic analyses to complement structural data.
• Site-directed mutagenesis to confirm protein-ligand interactions.

Main Results:

• Crystal structures of CYP3A4 with three (ternary) and six (senary) caffeine molecules were determined.
• Caffeine molecules were observed in the active site, substrate channel, and a peripheral site.
• Specific binding modes, including aromatic stacking and polar contacts, were identified.
• Key residues (R212, T224, F219) were implicated in caffeine binding and association.

Conclusions:

• The study provides unprecedented structural insights into how multiple substrates, like caffeine, can bind to CYP3A4.
• Observed binding modes suggest potential mechanisms for product inhibition and influence on enzyme turnover.
• Findings enhance understanding of purine-based drug interactions and CYP3A4-mediated drug-drug interactions.